Point72 (DIFC)’s Amylyx Pharmaceuticals AMLX Stock Holding History

Point72 (DIFC)’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$81.1K	Buy	+5,967	New	+$56.2K	0.01%	627
2025 Q2	–	Sell	-5,047	Closed	-$17.9K	–	1532
2025 Q1	$17.9K	Buy	5,047 +251	+5%	+$893	﹤0.01%	1367
2024 Q4	$18.1K	Buy	+4,796	New	+$22.6K	﹤0.01%	1279
2024 Q3	–	Sell	-25,953	Closed	-$49.3K	–	1418
2024 Q2	$49.3K	Sell	25,953 -23,040	-47%	-$44.6K	﹤0.01%	1093
2024 Q1	$139K	Buy	+48,993	New	+$641K	﹤0.01%	1035

Other funds holding AMLX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Point72 (DIFC)'s AMLX Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2025: 5,967 shares worth $81.1K. The stake represents 0.01% of the portfolio and ranks #627 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in AMLX as recently as Q1 2025.

Point72 (DIFC) first reported a position in AMLX in Q1 2024 and has held it in 5 quarters since. The position peaked at $139K in Q1 2024. 169 funds tracked by Wall St. Rank hold AMLX as of Q3 2025.

Point72 (DIFC) held 5,967 shares of Amylyx Pharmaceuticals worth $81.1K as of Q3 2025.
Amylyx Pharmaceuticals was a new Point72 (DIFC) position in Q3 2025.
Amylyx Pharmaceuticals made up 0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #627 holding.
Point72 (DIFC) first reported a position in Amylyx Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
Point72 (DIFC)'s Amylyx Pharmaceuticals position peaked at $139K in Q1 2024.
169 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.